AAV-mediated peripheral scFv's administration to reduce cerebral tau in adult P301S transgenic mice: Mono-vs. combination therapy.

Mol Ther Methods Clin Dev · 2025 · PMC12419030 · PMID 40932994

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Conversely, scFv-PHF1 and its combination with scFvMC1 delivered a nonsignificant trend toward reduction.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.